These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 3297420)
1. Fluorescence polarization immunoassay evaluated for screening for amphetamine and methamphetamine in urine. Caplan YH; Levine B; Goldberger B Clin Chem; 1987 Jul; 33(7):1200-2. PubMed ID: 3297420 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine. D'Nicuola J; Jones R; Levine B; Smith ML J Anal Toxicol; 1992; 16(4):211-3. PubMed ID: 1501473 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Abbott ADx Amphetamine/Methamphetamine II abused drug assay: comparison to TDx, EMIT, and GC/MS methods. Przekop MA; Manno JE; Kunsman GW; Cockerham KR; Manno BR J Anal Toxicol; 1991; 15(6):323-6. PubMed ID: 1779660 [TBL] [Abstract][Full Text] [Related]
4. Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay. Dasgupta A; Saldana S; Kinnaman G; Smith M; Johansen K Clin Chem; 1993 Jan; 39(1):104-8. PubMed ID: 8419030 [TBL] [Abstract][Full Text] [Related]
5. Comparison of three commercial amphetamine immunoassays for detection of methamphetamine, methylenedioxyamphetamine, methylenedioxymethamphetamine, and methylenedioxyethylamphetamine. Ruangyuttikarn W; Moody DE J Anal Toxicol; 1988; 12(4):229-33. PubMed ID: 2903272 [TBL] [Abstract][Full Text] [Related]
6. Urinary screening for alpha-OH triazolam by FPIA and EIA with confirmation by GC/MS. Fraser AD; Bryan W; Isner AF J Anal Toxicol; 1992; 16(6):347-50. PubMed ID: 1293398 [TBL] [Abstract][Full Text] [Related]
7. Response of the Emit II amphetamine/methamphetamine assay to specimens collected following use of Vicks inhalers. Poklis A; Jortani SA; Brown CS; Crooks CR J Anal Toxicol; 1993 Sep; 17(5):284-6. PubMed ID: 8107462 [TBL] [Abstract][Full Text] [Related]
8. Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing. Woodworth A; Saunders AN; Koenig JW; Moyer TP; Turk J; Dietzen DJ Clin Chem; 2006 Apr; 52(4):743-6. PubMed ID: 16455869 [TBL] [Abstract][Full Text] [Related]
9. Cross-reactivity of stimulants found in sports drug testing by two fluorescence polarization immunoassays. de la Torre R; Badia R; Gonzàlez G; García M; Pretel MJ; Farré M; Segura J J Anal Toxicol; 1996; 20(3):165-70. PubMed ID: 8735197 [TBL] [Abstract][Full Text] [Related]
10. Stereoselectivity of the TDxADx/FLx Amphetamine/Methamphetamine II amphetamine/methamphetamine immunoassay--response of urine specimens following nasal inhaler use. Poklis A; Moore KA J Toxicol Clin Toxicol; 1995; 33(1):35-41. PubMed ID: 7837311 [TBL] [Abstract][Full Text] [Related]
11. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability. Dextraze P; Griffiths WC; Camara P; Audette L; Rosner M Ann Clin Lab Sci; 1989; 19(2):133-8. PubMed ID: 2546480 [TBL] [Abstract][Full Text] [Related]
12. Determination of total and free phenytoin in serum by non-isotopic immunoassays and gas chromatography. Külpmann WR; Gey S; Beneking M; Kohl B; Oellerich M J Clin Chem Clin Biochem; 1984 Nov; 22(11):773-9. PubMed ID: 6396367 [TBL] [Abstract][Full Text] [Related]
13. Amphetamine concentrations in human urine following single-dose administration of the calcium antagonist prenylamine-studies using fluorescence polarization immunoassay (FPIA) and GC-MS. Kraemer T; Roditis SK; Peters FT; Maurer HH J Anal Toxicol; 2003 Mar; 27(2):68-73. PubMed ID: 12669999 [TBL] [Abstract][Full Text] [Related]
14. Specific enzyme-multiplied immunoassay and fluorescence polarization immunoassay for cyclosporin compared with Cyclotrac [125I]radioimmunoassay. Morris RG; Saccoia NC; Ryall RG; Peacock MK; Sallustio BC Ther Drug Monit; 1992 Jun; 14(3):226-33. PubMed ID: 1412609 [TBL] [Abstract][Full Text] [Related]
15. Screening of amphetamine/methamphetamine and their derivatives in urine using FPIA and Triage 8 and the Scope and limits of a subsequent identification by means of the REMEDi HS system. Felscher D; Schulz K J Forensic Sci; 2000 Nov; 45(6):1327-31. PubMed ID: 11110193 [TBL] [Abstract][Full Text] [Related]
16. Determination of N-desmethylmethsuximide serum concentrations using enzyme-multiplied and fluorescence polarization immunoassays. Miles MV; Howlett CM; Tennison MB; Greenwood RS; Cross RE Ther Drug Monit; 1989; 11(3):337-42. PubMed ID: 2658212 [TBL] [Abstract][Full Text] [Related]
17. Fluorescence polarization immunoassay for ethosuximide evaluated and compared with two other immunoassay techniques. Stewart CF; Bottorff MB Clin Chem; 1986 Sep; 32(9):1781-3. PubMed ID: 3527483 [TBL] [Abstract][Full Text] [Related]
18. Buflomedil interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay. Papa P; Rocchi L; Mainardi C; Donzelli G Eur J Clin Chem Clin Biochem; 1997 May; 35(5):369-70. PubMed ID: 9189741 [TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzer. Oeltgen PR; Shank WA; Blouin RA; Clark T Ther Drug Monit; 1984; 6(3):360-7. PubMed ID: 6390799 [TBL] [Abstract][Full Text] [Related]
20. Reagent lot-to-lot variability in sensitivity for amphetamine with the Syva Emit II Monoclonal Amphetamine/Methamphetamine assay. Singh J J Anal Toxicol; 1997; 21(2):174-5. PubMed ID: 9083839 [No Abstract] [Full Text] [Related] [Next] [New Search]